O. Hopfer

发表

Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay

D. Nowak, W. Hofmann, M. Neumann, 2013, Journal of Medical Genetics.

Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.

E. Thiel, F. Wagner, D. Nowak, 2009, Experimental hematology.

Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism

E. Thiel, D. Nowak, W. Hofmann, 2006, International journal of medical sciences.

[Tumor-induced hypercalcemia].

M. Kiehl, O. Hopfer, A. Gawliczek, 2013, Der Internist.

The Notch pathway in ovarian carcinomas and adenomas

M. Fey, S. Aebi, O. Hopfer, 2005, British Journal of Cancer.

Detection of differential mitotic cell age in bone marrow CD34(+) cells from patients with myelodysplastic syndrome and acute leukemia by analysis of an epigenetic molecular clock DNA signature.

E. Thiel, D. Nowak, W. Hofmann, 2010, Experimental hematology.

Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity. A randomized clinical trial

N. Halama, L. Bullinger, M. Addo, 2022, medRxiv.

Rationale and Design of GnG-Trial: A Randomized Phase-III Study to Compare Two Schedules of Gemtuzumab Ozogamicin as Adjunct to Intensive Induction Therapy and to Compare Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Older Patients with Newly Diagnosed AML

R. Schlenk, M. Görner, M. Kieser, 2021 .

Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis

E. Thiel, M. Reissmann, D. Nowak, 2012, European journal of haematology.

DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.

E. Thiel, W. Hofmann, D. Hoelzer, 2007, Experimental hematology.

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

N. Halama, L. Bullinger, R. Schlenk, 2022, Nature Cancer.

S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION

N. Halama, R. Schlenk, F. Herth, 2022, HemaSphere.

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

U. Germing, G. Kobbe, R. Haas, 2018, Annals of Hematology.

Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.

E. Thiel, W. Hofmann, D. Hoelzer, 2009, Leukemia research.

Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma

A. Baraniskin, R. Schroers, D. Vangala, 2019, Haematologica.